IDNA | iShares Genomics Immunology and Healthcare ETFAMEXETF golden cross and death cross projections, cross tests and history

$42.47
+$0.77 (+1.85%)

iShares Genomics Immunology and Healthcare ETF (IDNA) is an AMEX-listed ETF that Cruxta has tracked for 50/200 crosses since 2021.

The 50 SMA has sat above the 200 on the daily since Sep 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $42.47 vs 50 $40.91 / 200 $33.38
Projection
No cross projected
Test
No active test
Last cross
Golden cross 5 Sep 2025 ยท projected 25 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $42.76 vs 50 $32.13 / 200 $25.24
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 23 Mar 2026 ยท projected 30 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $42.47 vs 50 $41.72 / 200 $37.23
Projection
No cross projected
Test
No active test
Last cross
Golden cross 13 Jul 2023 ยท not projected

Cross history

6
crosses on record since 2021
4 golden2 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
week of 23 Mar 2026Golden moderateweekly30 bars outNot tested
5 Sep 2025Golden moderatedaily25 bars outNot tested
30 Dec 2024Deathdaily25 bars out1 bar cross test
2 Feb 2024Goldendaily28 bars out2 bar cross test
13 Jul 2023Golden4-hournot projectedโ€”

About IDNA

ExchangeAMEX
InstrumentETF
Median $ volume, 60 d$5.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2021

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.